Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 670 million infections and …

Background Cases of severe autoimmune blistering diseases (AIBDs) have recently been
reported in association with the severe acute respiratory syndrome coronavirus 2 (SARS …

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) comprises
granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic …

Vaccination against COVID-19 is one of the critical tools to provide herd immunity, reduce
mortality, and control the pandemic worldwide. Despite the safety of vaccination against …

As the coronavirus disease 2019 (COVID-19) pandemic is ongoing, and new variants of
severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) are emerging …

A comprehensive, up-to-date systematic review (SR) of the new-onset rheumatic immune-
mediated inflammatory diseases (R-IMIDs) following COVID-19 vaccinations is lacking …

Anti-SARS-CoV-2 vaccines are safe and effective, also in individuals with allergic and
immune-mediated diseases (IMDs). There are reports suggesting that vaccines may be able …

Introduction Since its emergence, there have been huge efforts to design vaccines against
coronavirus disease 2019 (COVID-19) to inhibit its interpersonal spread. Global vaccine …

The respiratory tract is the main infection site for severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), resulting in many admissions to intensive care centers in …

Vaccines against SARS-CoV-2 (COVID-19) proved beneficial for COVID-19 disease
attenuation and preventing virus spreading. Cumulative reports of the rarity of antineutrophil …